Aptar Pharma’s Nanopharm Wins “Excellence in Pharma” Award for SmartTrack™ at 2019 CPhI Pharma Awards

Aptar Pharma announces that Nanopharm has won an Excellence in Pharma Award at the 2019 CPhI Pharma Awards. Nanopharm, an Aptar Pharma company and part of our expanded services offering, won in the Contract Services and Outsourcing category for its recently-launched SmartTrack™ process.

Accepting the award were Dr. Jag Shur, CEO of Nanopharm, and Guillaume Brouet, Vice-President of Analytical, Regulatory and Scientific Affairs at Aptar Pharma.

The award was presented as part of the 16th annual CPhI Pharma Awards dinner, which took place Tuesday, November 5th at the Forum at Messe Frankfurt, Germany.

Established in 2004, the CPhI Pharma Awards are one of the most prestigious recognition’s in the Pharmaceutical industry today, and celebrate the innovation and dedication of companies and individuals who are driving the pharmaceutical industry forward. This year’s awards included 13 categories that span the entire industry’s supply chain.

A specialist in respiratory drug delivery services, Nanopharm is the world’s leading contract provider of orally inhaled and nasal drug product (OINDP) design and formulation development services to customers worldwide. Recognized for their advanced scientific understanding, Nanopharm offers an integrated solution approach via SmartTrack™.

SmartTrack™ is a novel integrated solution providing an alternative bioequivalence (BE) clinical endpoint approach. SmartTrack™ can dramatically decrease program costs, mitigate risk and expedite development from concept to delivery, ensuring that every aspect of a drug product development’s critical path is optimized.

“This award marks a significant milestone for our SmartTrack™ platform, and signifies the R&D endeavor at Nanopharm to develop alternative bioequivalence strategies for OINDPs,” commented Jag Shur, PhD, Chief Executive Officer of Nanopharm. “I would like to thank our employees, clients and partners in this success.”

Aptar Pharma President Gael Touya, who was on hand to present the Excellence in Pharma Drug Delivery Device and Packaging Awards at this year’s event added, “We are delighted that Nanopharm’s SmartTrack™ was recognized by the industry for its innovative approach. This reinforces the Aptar Pharma Services mission to further help customers during their entire product lifecycle of the drug product and deliver them a complete solution.”

Aptar Pharma, along with Nanopharm, are a main exhibitor at CPhI Worldwide 2019, which is taking place in Frankfurt, Germany from November 5 – 7. For several years, Aptar Pharma has had a significant presence at this major event in the pharmaceutical industry attended by over 45,000 Pharma professionals.

Download the press release here.